Condition
Bladder Cancer (BC) clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Bladder Cancer (BC) clinical trials that are recruiting, at sites in 3 countries (most in China (4), Sweden (1), United States (1)). 1 was first registered in the last 30 days. By phase: Phase 1 (1), Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1New in 30 days
- 3Countries
Newest Bladder Cancer (BC) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| BL-M07D1: T-bren vs standard platinum chemo for HER2-expressing metastatic urothelial cancer after anti-PD-(L)1 therapy | Phase 3 | Macon, Georgia and 1 other locations | Recruiting | Oct 13, 2026 |
| Trop2-targeted NIR-II probe to identify bladder cancer in ex vivo samples | Phase 2 | Kunming, Yunnan | Recruiting | Sep 30, 2026 |
| Non-invasive urine test to screen for urothelial cancer in adults with blood in urine | — | Zhengzhou, Henan | Recruiting | May 29, 2026 |
| Local radiotherapy for bladder cancer in patients not eligible for curative treatment | — | Umeå, Västerbotten County | Recruiting | Apr 13, 2026 |
| KD01 delivered directly into the bladder for bladder cancer | Phase 1 | Wuhan, Hubei | Recruiting | Jan 22, 2026 |
| Using a new imaging probe to identify non-muscle-invasive bladder cancer | — | Kunming, Yunnan | Recruiting | May 15, 2025 |
All recruiting trials (6)
-
BL-M07D1: T-bren vs standard platinum chemo for HER2-expressing metastatic urothelial cancer after anti-PD-(L)1 therapy
This trial tests whether T-bren can help people with HER2-expressing metastatic urothelial cancer who progressed after anti-PD-(L)1 therapy, compared with standard platinum-based chemotherapy.
-
Trop2-targeted NIR-II probe to identify bladder cancer in ex vivo samples
A phase 2 study tests whether a Trop2-targeted NIR-II fluorescent probe can highlight bladder cancer lesions on ex vivo bladder tissue from patients undergoing radical cystectomy.
-
Non-invasive urine test to screen for urothelial cancer in adults with blood in urine
A noninvasive urine test is being used to see if it can correctly identify urothelial cancer in adults who have blood in urine and a suspicious imaging finding.
-
Local radiotherapy for bladder cancer in patients not eligible for curative treatment
This trial tests whether adding local hypofractionated adaptive radiotherapy to standard care can improve survival and reduce symptoms for bladder cancer patients who aren’t candidates for curative treatment.
-
KD01 delivered directly into the bladder for bladder cancer
This Phase I test gives KD01—an oncolytic adenovirus—directly into the bladder to see if it is safe and shows early benefit for adults with high‑risk non‑muscle‑invasive disease or certain muscle‑invasive bladder cancers.
-
Using a new imaging probe to identify non-muscle-invasive bladder cancer
This study is testing a new imaging tool to see if it can help doctors better identify non-muscle-invasive bladder cancer during surgery.
Related topics
Quick answers
How many Bladder Cancer (BC) clinical trials are recruiting right now?
6, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (4 trials), Sweden (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.